Tuilleadh eolais ― Gaeilge

Urticaria is gnách go mbíonn tuí ardaithe an-thitchy i láthair. Uaireanta bíonn at sna fíocháin bhunúsacha ag gabháil leis. Is éard atá i gceist le cóireáil go príomha ná truicear a sheachaint, más eol. Áirítear le cógais chéad líne frithhistamíní níos nuaí, ar féidir iad a choigeartú go dáileoga níos airde más gá. Is féidir cógais eile cosúil le frithhistamíní níos sine, bacóirí H2, antagonists receptor leukotriene, frithhistamíní níos láidre, agus gearrchúrsaí corticosteroidí a chur leis mar thacaíocht bhreise. I gcásanna ina leanann urtacáire d’ainneoin na mbeart seo, d’fhéadfaí othair a atreorú chuig speisialtóirí le haghaidh teiripí breise amhail omalizumab nó cyclosporine.
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.

Imlíníonn an t-athbhreithniú seo na treoirlínte is déanaí maidir le cóireáil urtacáire agus cuireann sé tuiscintí nua ar na cúiseanna atá leis.
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.

Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids